ResearcherChina Medical UniversityNo recent work listed

Ming‐Xin An

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-2730-4484; OpenAlex author ID A5049650598. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper

Papers 2

BAG3 Suppresses Loading of Ago2 to IL6 mRNA in Pancreatic Ductal Adenocarcinoma. First author DOI 10.3389/fonc.2019.00225 ↗
BAG3 directly stabilizes Hexokinase 2 mRNA and promotes aerobic glycolysis in pancreatic cancer cells. Co-author DOI 10.1083/jcb.201701064 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hua‐Qin Wang · 2 shared papers, 2017–2019 · strength 0.17
- Paper BAG3 Suppresses Loading of Ago2 to IL6 mRNA in Pancreatic Ductal Adenocarcinoma. DOI 10.3389/fonc.2019.00225 ↗
- Paper BAG3 directly stabilizes Hexokinase 2 mRNA and promotes aerobic glycolysis in pancreatic cancer cells. DOI 10.1083/jcb.201701064 ↗
Chao Richard Li · 1 shared paper, 2019 · strength 0.10
- Paper BAG3 Suppresses Loading of Ago2 to IL6 mRNA in Pancreatic Ductal Adenocarcinoma. DOI 10.3389/fonc.2019.00225 ↗
Jia Teng Sun · 1 shared paper, 2017 · strength 0.07
- Paper BAG3 directly stabilizes Hexokinase 2 mRNA and promotes aerobic glycolysis in pancreatic cancer cells. DOI 10.1083/jcb.201701064 ↗
Xinyu Li · 1 shared paper, 2017 · strength 0.07
- Paper BAG3 directly stabilizes Hexokinase 2 mRNA and promotes aerobic glycolysis in pancreatic cancer cells. DOI 10.1083/jcb.201701064 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.